24
19
1
49
2
2
2c
1b
1d
18
34
8c
1d
2 29
1d
25
Eleanor P. Taranto, MD
88
8c
Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
7
5f
Department: Medicine
4
1
b
1d
46
Contact information
44
4
3
3
3
2
29
4
b
1f
44
1102 Maloney Building
4d Hospital of the University of Pennsylvania
Philadelphia, PA 19104
26
4d Hospital of the University of Pennsylvania
Philadelphia, PA 19104
35
f
13
Education:
21 7 AB 15 (History ) c
2e Princeton University , 2013.
21 8 N/A 2d (Post-Bac Premedical Certificate ) c
2f Georgetown University , 2014.
21 7 MD 22 (Medicine with Honors ) c
50 Pritzker School of Medicine, The University of Chicago , 2019.
21 9 MSCE 37 (Master of Science in Clinical Epidemiology) c
34 Univeristy of Pennsylvania , 2025.
c
3
3
3
3
8d
Permanent link21 7 AB 15 (History ) c
2e Princeton University , 2013.
21 8 N/A 2d (Post-Bac Premedical Certificate ) c
2f Georgetown University , 2014.
21 7 MD 22 (Medicine with Honors ) c
50 Pritzker School of Medicine, The University of Chicago , 2019.
21 9 MSCE 37 (Master of Science in Clinical Epidemiology) c
34 Univeristy of Pennsylvania , 2025.
c
2 29
21
1e
1d
24
2b
29
27
23
29f E. P. Taranto , W. Fawn , C. Desirae , E. Walinsky , S. Deluca , L. Bayne, E. P. Wileyto, A. Shirali, C. J. Robbins, Y. Abdou,J. Anampa, M. Balic, J. V. Canzoniero, N. C. Chen, F. Howard, L. Huppert, A. Kahn, C. Mainor, J. Mouabbi, V. Nair, T.Degeer, J. Weidler, T. McNicholas, C. Serway, J. Reischl, M. Bates, R. Monroe, D. L. Rimm, A. DeMichele: Quantifyher (trial in progress): quantitative immunofluorescence and/or messenger rna to measure her2 expression in patients with metastatic breast cancer treated with trastuzumab deruxtecan (tbcrc066). San Antonio Breast Cancer Symposium Dec 2025.
b3 A. DeMichele, L. Bayne, E. Walinsky, L. Berry, S. Deluca, C. G. Smith, A. Chevalier, B. Ambasager, P. Sanchez, J. Heaven, E. Chislock, c9 T. Pan, J. Graves, G. Belka, J. Wang, E. Taranto, A. Nayak, M. Feldman, A. Clark, L. Chodosh: 5-year outcomes and ctdna findings in the clever trial targeting disseminated dormant tumor cells 47 San Antonio Breast Cancer Symposium Dec 2025.
24c Taranto E, Seewald NJ, Bayne LJ, Deluca S, Shih NC, Sanchez P, Nivar I, Ambasager B, Murray C, Chevalier A, Smith CG, Makhlin I, Rohn K, Goodspeed BL, Savage J, Wileyto P, Wang J, Belka G, Chislock E, Berry LR, Berry D, Nayak A, Feldman M, Clark AS, Chodosh LA, & DeMichele A.: Circulating tumor DNA (ctDNA), dormant disseminated tumor cells (DTCs) and recurrence outcomes in breast cancer survivors on the SURMOUNT Study. San Antonio Breast Cancer Symposium, San Antonio, TX. Dec 2024 Notes: "Poster Presentation"
1e4 Taranto E, Hwang WT, Alfaro M, Surapaneni AS, Gill SK, Feldman T, Randall MP, Spinner MA, Furqan F, Shah NN, Samara Y, Mei MG, Herrera AF, Moskowitz A, Shah GL, & Svoboda J.: Engraftment Syndrome during Autologous Stem Cell Transplant in Hodgkin Lymphoma Patients Treated with Checkpoint Inhibitors: A Multicenter Retrospective analysis. ASH Annual Meeting, San Diego, CA. Dec 2023 Notes: "Poster Presentation"
d6 Taranto E, Barta S, Bhansali R.: Central Nervous System Relapse in T and NK Cell Lymphomas. Curr Hematol Malig Rep 18(6): 243-251. Dec 2023.
1d5 Merryman R, Redd R, Taranto E, Ahmed G, Jeter E, McHugh K, Brown J, Crombie J, Davids M, Fisher D, Freedman A, Jacobsen E, Jacobson C, Kim A, LaCasce A, Lampson B, Ng S, Odejide O, Dahi P, Nieto Y, Joyce R, Chen Y, Herrera A, Armand P.: Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation. Blood Adv 7(17): 4748-4759. Sep 2023.
19b Merryman R, Spilberg G, Mondello P, Redd R, Taranto E, Ahmed G, Jeter E, Chase M, Salles G, Zelenetz A, Brown J, Crombie J, Davids M, Fisher D, Freedman A, Jacobsen E, Jacobson C, Kim A, LaCasce A, Lampson B, Ng S, Odejide O, Armand P, Jacene H. : Interim Positron Emission Tomography during Frontline Chemoimmunotherapy for Follicular Lymphoma. Hemasphere 2a 7(2): e826. Jan 2023.
1ca Taranto E, Redd R, Jeter E, McHugh K, Crombie JL, Fisher DC, Jacobsen E, Jacobson CA, Kim AI, Odejide OO, Dahi PB, Nieto Y, Joyce RM, Chen YB, Bonjoc KC, Chaudhry A, Herrera AF, Armand P, Merryman RW.: Prognostic Value of Minimal Residual Disease among Patients with Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation. Leuk Lymphoma 63(12): 2912-2917. Dec 2022.
120 Kline J, Heusinkveld L, Taranto E, Martin C, Tomasi A, Hsu I, Cho K, Khillan J, Murphy P & Pontejo S.: Structural and functional analysis of Ccr1l1, a Rodentia-restricted eosinophil-selective chemokine receptor homologue. J Biol Chem 2 2f 296: 100373. Jan-Jun 2021.
2c
7
1d
1f
Selected Publications
f1 DeMichele, A. and Taranto, E.: Evaluating the clinical utility of ctDNA testing to identify molecular cancer progression – lessons from SERENA-6. NPJ Breast Jan 2026.29f E. P. Taranto , W. Fawn , C. Desirae , E. Walinsky , S. Deluca , L. Bayne, E. P. Wileyto, A. Shirali, C. J. Robbins, Y. Abdou,J. Anampa, M. Balic, J. V. Canzoniero, N. C. Chen, F. Howard, L. Huppert, A. Kahn, C. Mainor, J. Mouabbi, V. Nair, T.Degeer, J. Weidler, T. McNicholas, C. Serway, J. Reischl, M. Bates, R. Monroe, D. L. Rimm, A. DeMichele: Quantifyher (trial in progress): quantitative immunofluorescence and/or messenger rna to measure her2 expression in patients with metastatic breast cancer treated with trastuzumab deruxtecan (tbcrc066). San Antonio Breast Cancer Symposium Dec 2025.
b3 A. DeMichele, L. Bayne, E. Walinsky, L. Berry, S. Deluca, C. G. Smith, A. Chevalier, B. Ambasager, P. Sanchez, J. Heaven, E. Chislock, c9 T. Pan, J. Graves, G. Belka, J. Wang, E. Taranto, A. Nayak, M. Feldman, A. Clark, L. Chodosh: 5-year outcomes and ctdna findings in the clever trial targeting disseminated dormant tumor cells 47 San Antonio Breast Cancer Symposium Dec 2025.
24c Taranto E, Seewald NJ, Bayne LJ, Deluca S, Shih NC, Sanchez P, Nivar I, Ambasager B, Murray C, Chevalier A, Smith CG, Makhlin I, Rohn K, Goodspeed BL, Savage J, Wileyto P, Wang J, Belka G, Chislock E, Berry LR, Berry D, Nayak A, Feldman M, Clark AS, Chodosh LA, & DeMichele A.: Circulating tumor DNA (ctDNA), dormant disseminated tumor cells (DTCs) and recurrence outcomes in breast cancer survivors on the SURMOUNT Study. San Antonio Breast Cancer Symposium, San Antonio, TX. Dec 2024 Notes: "Poster Presentation"
1e4 Taranto E, Hwang WT, Alfaro M, Surapaneni AS, Gill SK, Feldman T, Randall MP, Spinner MA, Furqan F, Shah NN, Samara Y, Mei MG, Herrera AF, Moskowitz A, Shah GL, & Svoboda J.: Engraftment Syndrome during Autologous Stem Cell Transplant in Hodgkin Lymphoma Patients Treated with Checkpoint Inhibitors: A Multicenter Retrospective analysis. ASH Annual Meeting, San Diego, CA. Dec 2023 Notes: "Poster Presentation"
d6 Taranto E, Barta S, Bhansali R.: Central Nervous System Relapse in T and NK Cell Lymphomas. Curr Hematol Malig Rep 18(6): 243-251. Dec 2023.
1d5 Merryman R, Redd R, Taranto E, Ahmed G, Jeter E, McHugh K, Brown J, Crombie J, Davids M, Fisher D, Freedman A, Jacobsen E, Jacobson C, Kim A, LaCasce A, Lampson B, Ng S, Odejide O, Dahi P, Nieto Y, Joyce R, Chen Y, Herrera A, Armand P.: Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation. Blood Adv 7(17): 4748-4759. Sep 2023.
19b Merryman R, Spilberg G, Mondello P, Redd R, Taranto E, Ahmed G, Jeter E, Chase M, Salles G, Zelenetz A, Brown J, Crombie J, Davids M, Fisher D, Freedman A, Jacobsen E, Jacobson C, Kim A, LaCasce A, Lampson B, Ng S, Odejide O, Armand P, Jacene H. : Interim Positron Emission Tomography during Frontline Chemoimmunotherapy for Follicular Lymphoma. Hemasphere 2a 7(2): e826. Jan 2023.
1ca Taranto E, Redd R, Jeter E, McHugh K, Crombie JL, Fisher DC, Jacobsen E, Jacobson CA, Kim AI, Odejide OO, Dahi PB, Nieto Y, Joyce RM, Chen YB, Bonjoc KC, Chaudhry A, Herrera AF, Armand P, Merryman RW.: Prognostic Value of Minimal Residual Disease among Patients with Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation. Leuk Lymphoma 63(12): 2912-2917. Dec 2022.
120 Kline J, Heusinkveld L, Taranto E, Martin C, Tomasi A, Hsu I, Cho K, Khillan J, Murphy P & Pontejo S.: Structural and functional analysis of Ccr1l1, a Rodentia-restricted eosinophil-selective chemokine receptor homologue. J Biol Chem 2 2f 296: 100373. Jan-Jun 2021.
2c
44
23
Back to Top
1b
1d
18